Reading IREN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IREN free→Reading IREN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track IREN free→NASDAQFinancialsCapital MarketsSnapshot 2026-07-08
IREN's growth depends on the performance of the Financials sector. If sector leaders like MS and GS continue to beat earnings, IREN could benefit. Revenue growth is uncertain, and the latest results are not available. IREN trades at a high multiple compared to peers, which suggests it looks expensive. If major banks miss earnings or guide lower, IREN's growth could weaken. Peer multiples imply a price about 333% below where it trades. This read is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 5 valuation methods, at three horizons. Current price $43.01. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Trading +368% versus the 12-month peer-multiple consensus (looks stretched on this basis).
Looks more expensive than peers.
Self-history needs ~20 months of data.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
via XLF
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
No qualifying priorities for this snapshot. Check back after the next refresh.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$526.
How much price usually moves either way.
On a bad day, this stock has moved -$1,004.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $5,862.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-08
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
No named catalysts to watch right now. Check back after the next earnings report.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for IREN yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
No material events in the last 90 days.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Trailing four: 2025-Q3, 2026-Q1, 2026-Q2, 2026-Q3
A side-by-side read on sector standing, valuation, and risk versus peers.
| Stock | Sector standing | Risk |
|---|---|---|
IREN IREN Ltd | Below typical Show detailsSector percentile: 10 of 100 | elevated |
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-07-08.